Search research articles
Contact Us
Filters
Showing results (51-60 of 370) with videos related to
Page
of 37
Sort By:
Minerva Medica
|
June 2, 1978
[Diurnal variations in glucose tolerance in normal subjects and changes induced by oral glibenclamide]
G Pagano, A Diana, E Pisu, et al.
Minerva Dietologica E Gastroenterologica
|
October 1, 1987
[Treatment with protein-sparing modified fasting (Nutroclin) in hospitalized obese non-diabetics and type II diabetics]
V Tagliaferro, S Marena, C Marengo, et al.
Prostaglandins & Other Lipid Mediators
|
September 10, 1999
The binding of apolipoprotein H (beta2-Glycoprotein I) to lipoproteins
R Gambino, G Ruiu, G Pagano, et al.
Chemistry and Physics of Lipids
|
March 4, 2000
Study of the glycosylation of apolipoprotein H
R Gambino, G Ruiu, G Pagano, et al.
Atherosclerosis
|
June 1, 1988
Effect of short-term treatment with bezafibrate on plasma fibrinogen, fibrinopeptide A, platelet activation and blood filterability in atherosclerotic hyperfibrinogenemic patients
G Niort, A Bulgarelli, M Cassader, et al.
Journal of Lipid Mediators and Cell Signalling
|
April 3, 1998
Characterization and representative structures of N-oligosaccharides bound to apolipoprotein H
R Gambino, G Ruiu, G Pagano, et al.
Diabetes, Nutrition & Metabolism
|
November 26, 2003
Data sources and validity of epidemiological studies on diabetes
G Bruno, F Merletti, A Biggeri, et al.
Annali Dell'Istituto Superiore Di Sanita
|
January 25, 2000
[The Italian Fanconi Anemia Registry]
A Zatterale, R Calzone, E Montone, et al.
Journal of Protein Chemistry
|
May 20, 1999
Apolipoprotein H is not affected by in vitro glycosylation
R Gambino, G Ruiu, G Pagano, et al.
Panminerva Medica
|
March 1, 1977
Plasma insulin detection in the study of prediabetic subjects
G Lenti, G Pagano, M Trovati, et al.
Page
of 37
Search research articles
Search
Showing results (51-60 of 370) with videos related to
Sort By:
Page
of 37
Minerva Medica
|
June 2, 1978
[Diurnal variations in glucose tolerance in normal subjects and changes induced by oral glibenclamide]
G Pagano, A Diana, E Pisu, et al.
Minerva Dietologica E Gastroenterologica
|
October 1, 1987
[Treatment with protein-sparing modified fasting (Nutroclin) in hospitalized obese non-diabetics and type II diabetics]
V Tagliaferro, S Marena, C Marengo, et al.
Prostaglandins & Other Lipid Mediators
|
September 10, 1999
The binding of apolipoprotein H (beta2-Glycoprotein I) to lipoproteins
R Gambino, G Ruiu, G Pagano, et al.
Chemistry and Physics of Lipids
|
March 4, 2000
Study of the glycosylation of apolipoprotein H
R Gambino, G Ruiu, G Pagano, et al.
Atherosclerosis
|
June 1, 1988
Effect of short-term treatment with bezafibrate on plasma fibrinogen, fibrinopeptide A, platelet activation and blood filterability in atherosclerotic hyperfibrinogenemic patients
G Niort, A Bulgarelli, M Cassader, et al.
Journal of Lipid Mediators and Cell Signalling
|
April 3, 1998
Characterization and representative structures of N-oligosaccharides bound to apolipoprotein H
R Gambino, G Ruiu, G Pagano, et al.
Diabetes, Nutrition & Metabolism
|
November 26, 2003
Data sources and validity of epidemiological studies on diabetes
G Bruno, F Merletti, A Biggeri, et al.
Annali Dell'Istituto Superiore Di Sanita
|
January 25, 2000
[The Italian Fanconi Anemia Registry]
A Zatterale, R Calzone, E Montone, et al.
Journal of Protein Chemistry
|
May 20, 1999
Apolipoprotein H is not affected by in vitro glycosylation
R Gambino, G Ruiu, G Pagano, et al.
Panminerva Medica
|
March 1, 1977
Plasma insulin detection in the study of prediabetic subjects
G Lenti, G Pagano, M Trovati, et al.
Page
of 37